ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,356Medicare Part D Prescriptions Filled, Including Refills

Rank: 402 out of 2588

$539K Total Retail Price of All Prescriptions

Rank: 401 out of 2588

391 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

13% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 596 515 1 1
LEVOTHYROXINE SODIUM 593 507 2 2
AMLODIPINE BESYLATE 409 381 3 4
METFORMIN HCL 303 261 4 8
LISINOPRIL 276 239 5 3
OMEPRAZOLE 269 227 6 6
HYDROCODONE-ACETAMINOPHEN 240 171 S3 7 7
METOPROLOL SUCCINATE 197 189 8 12
ALENDRONATE SODIUM 190 174 9 21
HYDROCHLOROTHIAZIDE 145 135 10 13
CARVEDILOL 134 130 11 20
FUROSEMIDE 125 112 12 5
ENALAPRIL MALEATE 125 121 12 31
ATORVASTATIN CALCIUM 124 102 14 11
SERTRALINE HCL 117 86 15 26
LOVASTATIN 104 104 16 34
WARFARIN SODIUM 103 92 17 10
ATENOLOL 103 96 17 14
METOPROLOL TARTRATE 98 91 19 9
ADVAIR DISKUS 90 76 20 48
ESCITALOPRAM OXALATE 84 18 21 68
TRIAMTERENE-HCTZ 82 74 22 46
PROAIR HFA 82 52 22 50
PRAVASTATIN SODIUM 79 71 24 16
BENAZEPRIL HCL 75 73 25 84
DICLOFENAC SODIUM 73 72 26 124
CLOPIDOGREL 73 71 26 30
POTASSIUM CHLORIDE 73 71 26 15
PAROXETINE HCL 66 49 29 71
LOSARTAN POTASSIUM 65 54 30 17
COMBIVENT 63 38 31 145
FLUTICASONE PROPIONATE 63 51 31 40
TRAZODONE HCL 60 52 33 61
DONEPEZIL HCL 60 60 33 22
DIGOXIN 59 59 35 38
SINGULAIR 59 50 35 94
CITALOPRAM HBR 58 55 37 27
ACTOS 57 45 38 105
FELODIPINE ER 56 54 39 108
ISOSORBIDE MONONITRATE ER 55 51 40 49
GLIPIZIDE ER 55 50 40 73
TRAMADOL HCL 54 47 42 19
TAMSULOSIN HCL 53 37 43 23
CARBIDOPA-LEVODOPA 53 41 43 83
DIOVAN 53 44 43 29
BENICAR 52 40 46 143
GLIPIZIDE 52 48 46 44
DILTIAZEM 24HR CD 52 40 46 98
FAMOTIDINE 51 41 49 36
POLYETHYLENE GLYCOL 3350 50 25 50 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.